Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.

Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S.

Clin Microbiol Rev. 2019 Aug 28;32(4). pii: e00031-19. doi: 10.1128/CMR.00031-19. Print 2019 Sep 18. Review.

PMID:
31462403
2.

Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.

Sánchez-Diener I, Zamorano L, Peña C, Ocampo-Sosa A, Cabot G, Gómez-Zorrilla S, Almirante B, Aguilar M, Granados A, Calbo E, Rodriguez-Baño J, Rodríguez-López F, Tubau F, Martínez-Martínez L, Navas A, Oliver A.

Clin Microbiol Infect. 2019 Jul 6. pii: S1198-743X(19)30389-1. doi: 10.1016/j.cmi.2019.06.034. [Epub ahead of print]

PMID:
31288102
3.

Impact of De-escalation on Prognosis of Patients With Bacteremia due to Enterobacteriaceae: A Post Hoc Analysis From a Multicenter Prospective Cohort.

Palacios-Baena ZR, Delgado-Valverde M, Valiente Méndez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurguí M, De la Calle C, García-Álvarez L, Ramos L, Gozalo M, Morosini MI, Molina J, Causse M, Pascual Á, Rodríguez-Baño J; REIPI/GEIRAS-SEIMC Bacteraemia-MIC Group .

Clin Infect Dis. 2019 Aug 30;69(6):956-962. doi: 10.1093/cid/ciy1032.

PMID:
30535051
4.

Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain".

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e02352-17. doi: 10.1128/AAC.02352-17. Print 2018 Jan. No abstract available.

5.

Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01589-17. doi: 10.1128/AAC.01589-17. Print 2017 Nov. Erratum in: Antimicrob Agents Chemother. 2017 Dec 21;62(1):.

6.

MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae.

Delgado-Valverde M, Valiente-Mendez A, Torres E, Almirante B, Gómez-Zorrilla S, Borrell N, Aller-García AI, Gurgui M, Almela M, Sanz M, Bou G, Martínez-Martínez L, Cantón R, Antonio Lepe J, Causse M, Gutiérrez-Gutiérrez B, Pascual Á, Rodríguez-Baño J; REIPI/GEIH-SEIMC BACTERAEMIA-MIC Group.

J Antimicrob Chemother. 2017 May 1;72(5):1478-1487. doi: 10.1093/jac/dkw562.

PMID:
28093484
7.

Understanding the acute inflammatory response to Pseudomonas aeruginosa infection: differences between susceptible and multidrug-resistant strains in a mouse peritonitis model.

Gómez-Zorrilla S, Calatayud L, Juan C, Cabot G, Tubau F, Oliver A, Dominguez MA, Ariza J, Peña C.

Int J Antimicrob Agents. 2017 Feb;49(2):198-203. doi: 10.1016/j.ijantimicag.2016.10.016. Epub 2016 Nov 28.

PMID:
27939091
8.

Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study.

Gómez-Zorrilla S, Morandeira F, Castro MJ, Tubau F, Periche E, Cañizares R, Dominguez MA, Ariza J, Peña C.

Microb Drug Resist. 2017 Jun;23(4):523-530. doi: 10.1089/mdr.2016.0144. Epub 2016 Oct 18.

9.

Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies.

Gómez-Zorrilla S, Juan C, Cabot G, Camoez M, Tubau F, Oliver A, Dominguez MA, Ariza J, Peña C.

Int J Antimicrob Agents. 2016 May;47(5):368-74. doi: 10.1016/j.ijantimicag.2016.02.010. Epub 2016 Mar 24.

PMID:
27079153
10.

Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project.

Delgado-Valverde M, Torres E, Valiente-Mendez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurgui M, Almela M, García-Álvarez L, Fontecoba-Sánchez MC, Martínez-Martínez L, Cantón R, Praena J, Causse M, Gutiérrez-Gutiérrez B, Roberts JA, Farkas A, Pascual Á, Rodríguez-Baño J; REIPI/GEIH-SEIMC BACTERAEMIA-MIC Group.

J Antimicrob Chemother. 2016 Feb;71(2):521-30. doi: 10.1093/jac/dkv362. Epub 2015 Nov 3.

PMID:
26538507
11.

Prospective observational study of prior rectal colonization status as a predictor for subsequent development of Pseudomonas aeruginosa clinical infections.

Gómez-Zorrilla S, Camoez M, Tubau F, Cañizares R, Periche E, Dominguez MA, Ariza J, Peña C.

Antimicrob Agents Chemother. 2015 Sep;59(9):5213-9. doi: 10.1128/AAC.04636-14. Epub 2015 Jun 15.

12.

Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.

Peña C, Cabot G, Gómez-Zorrilla S, Zamorano L, Ocampo-Sosa A, Murillas J, Almirante B, Pomar V, Aguilar M, Granados A, Calbo E, Rodríguez-Baño J, Rodríguez-López F, Tubau F, Martínez-Martínez L, Oliver A; Spanish Network for Research in Infectious Diseases (REIPI).

Clin Infect Dis. 2015 Feb 15;60(4):539-48. doi: 10.1093/cid/ciu866. Epub 2014 Nov 6.

PMID:
25378459
13.

Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients.

Gómez-Zorrilla S, Camoez M, Tubau F, Periche E, Cañizares R, Dominguez MA, Ariza J, Peña C.

Antimicrob Agents Chemother. 2014 Oct;58(10):5863-70. doi: 10.1128/AAC.03419-14. Epub 2014 Jul 21.

14.

Streptococcus suis infection and malignancy in man, Spain.

Gómez-Zorrilla S, Ardanuy C, Lora-Tamayo J, Cámara J, García-Somoza D, Peña C, Ariza J.

Emerg Infect Dis. 2014 Jun;20(6):1067-8. doi: 10.3201/eid2006.131167. No abstract available.

15.

Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality.

Peña C, Gómez-Zorrilla S, Oriol I, Tubau F, Dominguez MA, Pujol M, Ariza J.

Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):413-20. doi: 10.1007/s10096-012-1758-8. Epub 2013 Jan 24.

PMID:
23344827
16.

Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome.

Gómez-Zorrilla S, Ferraz AV, Pedrós C, Lemus M, Peña C.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):e20. doi: 10.1345/aph.1R084. Epub 2012 Jul 3.

PMID:
22764327
17.

Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.

Peña C, Gómez-Zorrilla S, Suarez C, Dominguez MA, Tubau F, Arch O, Oliver A, Pujol M, Ariza J.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2791-7. Epub 2012 May 4.

PMID:
22552893
18.

[Fever and neutropenia in a 20-year-old woman].

Gomez-Zorrilla S, Alvarez Miezentseva V, Villena Salinas N, Pujol R.

Med Clin (Barc). 2012 Mar 17;138(6):262-9. doi: 10.1016/j.medcli.2011.11.018. Epub 2012 Jan 16. Spanish. No abstract available.

PMID:
22257603

Supplemental Content

Loading ...
Support Center